Total Payments
$47,973
2024 Payments
$6,085
Companies
34
Transactions
236
Medicare Patients
1,211
Medicare Billing
$119,877
Payment Breakdown by Category
Education$32,657 (68.1%)
Food & Beverage$6,266 (13.1%)
Travel$4,887 (10.2%)
Other$4,000 (8.3%)
Consulting$150.00 (0.3%)
Gifts$13.57 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $32,657 | 13 | 68.1% |
| Food and Beverage | $6,266 | 198 | 13.1% |
| Travel and Lodging | $4,887 | 22 | 10.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 1 | 8.3% |
| Consulting Fee | $150.00 | 1 | 0.3% |
| Gift | $13.57 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $43,538 | 58 | $0 (2024) |
| Pulmonx Corporation | $1,233 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $505.07 | 42 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $401.73 | 26 | $0 (2023) |
| Grifols USA, LLC | $204.69 | 11 | $0 (2019) |
| United Therapeutics Corporation | $202.73 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $198.11 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $154.19 | 7 | $0 (2018) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $148.25 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,085 | 12 | INTUITIVE SURGICAL, INC. ($5,761) |
| 2023 | $32,989 | 38 | Intuitive Surgical, Inc. ($32,942) |
| 2022 | $4,882 | 16 | Intuitive Surgical, Inc. ($3,636) |
| 2021 | $1,231 | 9 | Intuitive Surgical, Inc. ($1,200) |
| 2020 | $150.37 | 9 | GlaxoSmithKline, LLC. ($61.10) |
| 2019 | $828.91 | 54 | GlaxoSmithKline, LLC. ($156.10) |
| 2018 | $947.01 | 54 | AstraZeneca Pharmaceuticals LP ($157.00) |
| 2017 | $859.20 | 44 | Astellas Pharma US Inc ($142.07) |
All Payment Transactions
236 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | KLS-Martin L.P. | — | Food and Beverage | Cash or cash equivalent | $48.24 | General |
| Category: Osteosynthesis | ||||||
| 11/12/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $40.91 | General |
| Category: SURGERY | ||||||
| 10/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: SURGERY | ||||||
| 10/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: SURGERY | ||||||
| 08/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 08/21/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $137.00 | General |
| Category: Peripheral Intervention | ||||||
| 07/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: SURGERY | ||||||
| 05/20/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | Cash or cash equivalent | $139.06 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 01/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 01/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: SURGERY | ||||||
| 01/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: SURGERY | ||||||
| 10/17/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $63.42 | General |
| Category: SURGERY | ||||||
| 08/02/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 08/02/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 07/27/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $504.80 | General |
| Category: SURGERY | ||||||
| 07/27/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 07/25/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $88.03 | General |
| Category: SURGERY | ||||||
| 06/16/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 06/16/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 06/09/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 06/09/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 06/06/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $47.70 | General |
| Category: SURGERY | ||||||
| 05/19/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 411 | 437 | $546,381 | $36,797 |
| 2022 | 7 | 221 | 338 | $117,651 | $39,084 |
| 2021 | 4 | 105 | 155 | $63,186 | $21,174 |
| 2020 | 11 | 474 | 503 | $72,659 | $22,822 |
Total Patients
1,211
Total Services
1,433
Medicare Billing
$119,877
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31640 | Removal of growth of lung airways using an endoscope | Facility | 2023 | 27 | 27 | $26,084 | $4,986 | 19.1% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 45 | 46 | $208,984 | $3,331 | 1.6% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 21 | 22 | $26,275 | $3,210 | 12.2% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 29 | 29 | $72,355 | $2,981 | 4.1% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 41 | 41 | $75,492 | $2,925 | 3.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 25 | $8,383 | $2,817 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $7,429 | $2,510 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 33 | $7,861 | $2,479 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $5,732 | $1,988 | 34.7% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 39 | 39 | $12,558 | $1,955 | 15.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,009 | $1,629 | 27.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 23 | $4,211 | $1,428 | 33.9% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 34 | 34 | $51,098 | $1,315 | 2.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 23 | $3,874 | $1,193 | 30.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,875 | $1,125 | 29.0% |
| 31633 | Needle biopsy of lobe of lung using an endoscope, each additional lobe | Facility | 2023 | 11 | 11 | $2,704 | $533.17 | 19.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 22 | 23 | $23,456 | $392.69 | 1.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 74 | 152 | $83,102 | $26,068 | 31.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 93 | $13,599 | $5,097 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 33 | $6,866 | $2,697 | 39.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $4,777 | $1,751 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,394 | $1,648 | 37.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 11 | 11 | $3,374 | $1,241 | 36.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 19 | $1,539 | $581.81 | 37.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 50 | 91 | $50,806 | $16,413 | 32.3% |
About Dr. Abhishek Kumar, M.D
Dr. Abhishek Kumar, M.D is a Pulmonary Disease healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1639443823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abhishek Kumar, M.D has received a total of $47,973 in payments from pharmaceutical and medical device companies, with $6,085 received in 2024. These payments were reported across 236 transactions from 34 companies. The most common payment nature is "Education" ($32,657).
As a Medicare-enrolled provider, Kumar has provided services to 1,211 Medicare beneficiaries, totaling 1,433 services with total Medicare billing of $119,877. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Dallas, TX
- Active Since 03/06/2012
- Last Updated 02/02/2026
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639443823
Products in Payments
- Da Vinci Surgical System (Device) $36,538
- DA VINCI SP (Device) $4,000
- DAVINCI XI (Device) $3,000
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,019
- NUCALA (Biological) $276.69
- ZERBAXA (Drug) $252.46
- CHARTIS CATHETER (Device) $213.98
- BEVESPI AEROSPHERE (Drug) $184.31
- TYVASO (Drug) $139.06
- Indigo System (Device) $137.00
- Prolastin-C Liquid (Biological) $120.44
- Xolair (Biological) $120.22
- TITAN ENDOSKELETON (Device) $105.98
- OFEV (Drug) $105.82
- TRELEGY ELLIPTA (Drug) $85.51
- BREO (Drug) $84.87
- Prolastin-C (Biological) $84.25
- LONHALA MAGNAIR (Drug) $83.50
- FASENRA (Drug) $80.65
- XOLAIR (Biological) $74.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Dallas
Dr. Mark Millard, M.d, M.D
Pulmonary Disease — Payments: $381,124
Pulmonary Disease $381,124
Dr. Fernando Torres, M.d, M.D
Pulmonary Disease — Payments: $247,706
Pulmonary Disease $247,706
Dr. Raksha Jain, Md, MD
Pulmonary Disease — Payments: $189,093
Pulmonary Disease $189,093
Dr. Kelly Chin, M.d, M.D
Pulmonary Disease — Payments: $103,886
Pulmonary Disease $103,886
Dr. Gary Weinstein, M.d, M.D
Pulmonary Disease — Payments: $102,068
Pulmonary Disease $102,068
Anthony Ortegon, Md, MD
Pulmonary Disease — Payments: $95,730
Pulmonary Disease $95,730